Key features and details
- Sheep polyclonal to Streptomycin
- Suitable for: Competitive ELISA
- Reacts with: Species independent
- Isotype: IgG
Product nameAnti-Streptomycin antibody
DescriptionSheep polyclonal to Streptomycin
Tested applicationsSuitable for: Competitive ELISAmore details
Species reactivityReacts with: Species independent
Chemical/ Small Molecule: Streptomycin conjugated to BSA.
The Life Science industry has been in the grips of a reproducibility crisis for a number of years. Abcam is leading the way in addressing this with our range of recombinant monoclonal antibodies and knockout edited cell lines for gold-standard validation. Please check that this product meets your needs before purchasing.
If you have any questions, special requirements or concerns, please send us an inquiry and/or contact our Support team ahead of purchase. Recommended alternatives for this product can be found below, along with publications, customer reviews and Q&As
Storage instructionsShipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles.
Storage bufferpH: 7.20
Preservative: 0.09% Sodium azide
Constituents: 0.0536% PBS, 0.87% Sodium chloride
Concentration information loading...
Purification notesImmunoglobulin fraction, pepared by caprylic acid and ammonium sulphate precipitation techniques.
The Abpromise guarantee
Our Abpromise guarantee covers the use of ab30593 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
RelevanceStreptomycin is an antibiotic produced by soil bacteria of the genus Streptomyces and is active against both gram positive and gram negative bacteria, including species resistant to other antibiotics, eg some streptococci, penicillin resistant staphylococci, and bacteria of the genera Proteus and Pseudomonas. Originally isolated by Selman A. Waksman and Albert Schatz in 1947, streptomycin is effective against tubercle bacilli and is a mainstay of tuberculosis therapy. Because streptomycin resistant tubercle bacilli emerge during treatment, the antibiotic is usually used in combination with one or more of the drugs isoniazid, ethambutol, and aminosalicylic acid. Streptomycin acts by inhibiting protein synthesis and damaging cell membranes in susceptible microorganisms. Possible side effects include injury to the kidneys and nerve damage that can result in dizziness and deafness.
To our knowledge, customised protocols are not required for this product. Please try the standard protocols listed below and let us know how you get on.
ab30593 has not yet been referenced specifically in any publications.